Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

This is the first of two papers which review issues concerning complementary medicines. The first reviews the extent of use of complementary medicines, and issues related to the regulation and pharmaceutical quality of these products; the second considers evidence for the efficacy of several well-known complementary medicines, and discusses complementary-medicines pharmacovigilance. The term complementary medicines describes a range of pharmaceutical-type preparations, including herbal medicines, homoeopathic remedies, essential oils and dietary supplements, which mainly sit outside conventional medicine. The use of complementary medicines is a popular healthcare approach in the UK, and there are signs that the use of such products is continuing to increase. Patients and the public use complementary medicines for health maintenance, for the treatment or prevention of minor ailments, and also for serious, chronic illnesses. The pervasive use of complementary medicines raises several concerns. Many of these arise because most complementary medicines are not licensed as medicines, and therefore evidence of quality, efficacy and safety is not required before marketing. The regulatory framework for herbal medicines and dietary supplements is currently under review. A new system for registration of traditional herbal medicines will ensure that marketed products meet standards for quality and safety. At present, the pharmaceutical quality of many complementary medicines is a cause for concern.

[1]  E. Ernst.  Toxic heavy metals and undeclared drugs in Asian herbal medicines. , 2002, Trends in pharmacological sciences.

[2]  L. Verotta,et al.  Hyperforin analogues from St. John's wort (Hypericum perforatum). , 2000, Journal of natural products.

[3]  J. Phillipson,et al.  St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties , 2001, The Journal of pharmacy and pharmacology.

[4]  E. Ernst,et al.  The BBC survey of complementary medicine use in the UK. , 2000, Complementary therapies in medicine.

[5]  R. Kessler,et al.  Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. , 1998, JAMA.

[6]  A. Vickers,et al.  What is complementary medicine? , 1999, BMJ.

[7]  R. Tisserand.  Essential Oil Safety: A Guide for Health Care Professionals , 1995 .

[8]  J. Mccormick.  EMIGRATION AND MENTAL SUBNORMALITY IN NORTHERN IRELAND , 1974 .

[9]  A. Morice.  ADULTERATED "HOMOEOPATHIC" CURE FOR ASTHMA , 1986, The Lancet.

[10]  E. Ernst.  The usage of complementary therapies by dermatological patients: a systematic review , 2000, The British journal of dermatology.

[11]  E. Ernst,et al.  Complementary and alternative therapies for treating multiple sclerosis symptoms: a systematic review. , 2000, Complementary therapies in medicine.

[12]  M. Nöldner,et al.  Antidepressant Activity of Hypericum Perforatum and Hyperforin: the Neglected Possibility , 1998, Pharmacopsychiatry.

[13]  E. Guadagnoli,et al.  Use of alternative medicine by women with early-stage breast cancer. , 1999, The New England journal of medicine.

[14]  P. Schmidt,et al.  Isolation, Purity Analysis and Stability of Hyperforin as a Standard Material from Hypericum perforatum L. , 1999, The Journal of pharmacy and pharmacology.

[15]  E. Ernst,et al.  Complementary therapies for depression: an overview. , 1998, Archives of general psychiatry.

[16]  J. Flaherty,et al.  Use of alternative therapies in older outpatients in the United States and Japan: prevalence, reporting patterns, and perceived effectiveness. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[17]  E. Ernst.  Complementary therapies for asthma: what patients use. , 1998, The Journal of asthma : official journal of the Association for the Care of Asthma.

[18]  J. Fischer,et al.  Parental attitude towards alternative medicine in the paediatric intensive care unit , 1999, European Journal of Pediatrics.

[19]  A. Vickers,et al.  Massage and Aromatherapy: A Guide for Health Professionals , 1996 .

[20]  E. Hemminki,et al.  A Survey on the use of Alternative Drugs During Pregnancy , 1991, Scandinavian journal of social medicine.

[21]  Ethnicity and physician-older patient communication about alternative therapies. , 2001, Journal of alternative and complementary medicine.

[22]  J. Astin.  Why patients use alternative medicine: results of a national study. , 1998, JAMA.

[23]  M. Verhoef,et al.  Alternative therapy use in neurologic diseases , 1999, Neurology.

[24]  E. Ernst,et al.  Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies. , 1998, British journal of clinical pharmacology.

[25]  S. Munn,et al.  Analysis of Chinese herbal creams prescribed for dermatological conditions , 1999, The Western journal of medicine.

[26]  H. Kerr,et al.  Arsenic content of homeopathic medicines. , 1986, Journal of toxicology. Clinical toxicology.

[27]  D. Theodorescu,et al.  Alternative medicine use in patients with localized prostate carcinoma treated with curative intent , 1999, Cancer.

[28]  E. Ernst,et al.  Prevalence of complementary/alternative medicine for children: a systematic review , 1999, European Journal of Pediatrics.

[29]  A. White,et al.  Complementary medicine — a definition , 1995 .

[30]  E. Ernst,et al.  Usage of complementary therapies in rheumatology: A systematic review , 2005, Clinical Rheumatology.

[31]  A. Maclennan,et al.  Prevalence and cost of alternative medicine in Australia , 1996, The Lancet.

[32]  J. Nicholl,et al.  Use and expenditure on complementary medicine in England: a population based survey. , 2001, Complementary therapies in medicine.

[33]  C. Bernstein,et al.  An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[34]  D. Luscombe,et al.  Nonprescription medicine use in a multiple sclerosis clinic population. , 2000, British journal of clinical pharmacology.

[35]  C. Vincent,et al.  The health beliefs and behaviors of three groups of complementary medicine and a general practice group of patients. , 1995, Journal of alternative and complementary medicine.

[36]  S. Bhattacharya,et al.  Hyperforin as a possible antidepressant component of hypericum extracts. , 1998, Life sciences.

[37]  E. Ernst.  The prevalence of complementary/Alternative medicine in cancer , 1998, Cancer.

[38]  M Kieser,et al.  St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. , 1998, Pharmacopsychiatry.

[39]  R. Koda,et al.  Determining hyperforin and hypericin content in eight brands of St. John's wort. , 2002, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[40]  Kathleen M. Fairfield,et al.  Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. , 1998, Archives of internal medicine.

[41]  J. Buckle.  Clinical Aromatherapy in Nursing , 1997 .